Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 41 (2) , 303-313.e1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trialThe Lancet, 2014
- Randomized, 1‐year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice‐daily premixed insulin versus basal insulin with either basal‐plus one prandial insulin or basal‐bolus up to three prandial injectionsDiabetes, Obesity and Metabolism, 2013
- Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glarginePatient Preference and Adherence, 2013
- Factors associated with injection omission/non‐adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabetes, Obesity and Metabolism, 2012
- Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabetic Medicine, 2012
- The effort required to achieve and maintain optimal glycemic controlJournal of Diabetes and its Complications, 2011
- Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic reviewJournal of Diabetes and its Complications, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Correlates of Insulin Injection OmissionDiabetes Care, 2010
- Defining and Characterizing the Progression of Type 2 DiabetesDiabetes Care, 2009